Harnessing random peptide mixtures to combat multidrug-resistant fungal infections
mBio · 13.05.2026 · 17 (5)
DOI: 10.1128/mbio.00400-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 13.05.2026. Verfasst von John Adeoye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Koret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel. Hauptthemen laut MEDLINE: Antifungal Agents, Drug Resistance, Multiple, Fungal, Antimicrobial Peptides. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation.
Abstract (Originalsprache)
Invasive fungal infections are associated with high mortality and are increasingly difficult to treat due to a limited antifungal arsenal and the rapid emergence of drug resistance. Novel therapeutic strategies that combine potent antifungal activity, low host toxicity, in vivo stability, and a reduced propensity for resistance development are urgently needed. Antimicrobial peptides (AMPs) stand out as a promising class of compounds to combat antimicrobial resistance. Leveraging the unique properties of AMPs, we previously developed a novel approach to synthesize random peptide mixtures (RPMs) with robust bactericidal activity against drug-resistant bacteria. Here, we evaluate the antifungal potential of RPMs and demonstrate species-dependent, broad-spectrum activity of FK20 (L-phenylalanine–L-lysine, 20-mer) against major human fungal pathogens, including Candida spp., Cryptococcus neoformans , and Aspergillus fumigatus , with particularly high potency against the multidrug-resistant pathogen Candida auris . Mechanistic analyses revealed rapid membrane and cell wall disruption accompanied by intracellular penetration, consistent with membrane-active antifungal activity. Importantly, experimental evolution assays demonstrated a markedly reduced capacity for resistance development in C. auris . FK20 inhibited biofilm formation and displayed substantial activity against mature, pre-formed biofilms, both alone and synergistically in combination with caspofungin. Finally, FK20 showed significant therapeutic efficacy in a murine model of systemic candidiasis. Collectively, these findings establish RPMs as a versatile antifungal platform with broad-spectrum activity, biofilm efficacy, and a low resistance footprint, highlighting their promise as a novel therapeutic strategy against drug-resistant fungal infections. IMPORTANCE The rising prevalence of invasive fungal infections, particularly among immunocompromised individuals, has become a critical public health concern. However, antifungal drug development has not kept pace with this growing need, and treatment options remain limited to a small number of drug classes. The emergence of multidrug-resistant fungal pathogens, such as Candida auris , further exacerbates this crisis by reducing the efficacy of existing therapeutics and increasing the risk of treatment failure. In this study, we evaluate the antifungal potential of FK20, a random peptide mixture (RPM) composed of L-phenylalanine and L-lysine. FK20 displays potent activity against C. auris and other clinically relevant Candida species, impairs biofilm formation, and exhibits synergy with caspofungin. Importantly, FK20 limits the emergence of resistance and demonstrates therapeutic efficacy in a murine model of systemic candidiasis. These findings establish RPMs as a promising new class of antifungals with broad-spectrum activity and clinical potential against drug-resistant fungal infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Koret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel.
- Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agricultural, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
- Laboratory of Microbiology, Center for Excellence in Research, Development & Innovation, Baku State University, Baku, Azerbaijan.
ORCID-Profile: John Adeoye, Zvi Hayouka, Neta Shlezinger
Förderung
- Israel Science Foundation
Zitieren
APA
Adeoye, J., Belo, Y., Rocha, M. C., Hayby, H., Israyilova, A., Hayouka, Z., & Shlezinger, N. (2026). Harnessing random peptide mixtures to combat multidrug-resistant fungal infections. mBio, 17(5). https://doi.org/10.1128/mbio.00400-26
Vancouver
Adeoye J, Belo Y, Rocha MC, Hayby H, Israyilova A, Hayouka Z, et al. Harnessing random peptide mixtures to combat multidrug-resistant fungal infections. mBio. 2026;17(5). doi:10.1128/mbio.00400-26
BibTeX
@article{Adeoye2026,
author = {Adeoye, John and Belo, Yael and Rocha, Marina Campos and Hayby, Hilla and Israyilova, Aygun and Hayouka, Zvi and Shlezinger, Neta},
title = {Harnessing random peptide mixtures to combat multidrug-resistant fungal infections},
journal = {mBio},
year = {2026},
volume = {17},
number = {5},
doi = {10.1128/mbio.00400-26}
}
EUVIMED